News

On April 28 2026, Broadridge announced that Tavira Financial selected its High‑Touch Order Management System (OMS) along with connectivity and middle‑office solutions. The OMS will cover order flow from initiation to post‑trade processing, while the connectivity stack will support multiple execution styles and asset classes. The agreement is intend...

Full article

Broadridge Financial Solutions announced the launch of its Central Risk and Liquidity Optimization Solution, powered by Tbricks, on April 24 2026. The platform consolidates smart order routing, multi‑asset market making, internalization, real‑time risk management, automated hedging, automatic IOI generation, and RFQ capabilities into a single front...

Full article

Management highlighted that market volatility is not expected to materially impact the pipeline, noting that deals are typically priced in advance. The company’s share price has risen 11.1 % since the beginning of the year, outperforming the S&P 500’s 3.2 % gain. EPRT will host an earnings conference call on Thursday, April 23, 2026 at 10:00 a.m. E...

Full article

The portfolio as of March 31, 2026 consists of 2,417 properties with a weighted average lease term of 14.6 years and a rent‑coverage ratio of 3.5x. The top 10 tenants provide 15.8 % of the cash‑base rental income (ABR), while the top 20 tenants account for 26 %. The company’s dividend policy was updated: the payout ratio increased to $0.31 per shar...

Full article

EPRT’s investment pipeline remains robust. The company closed $388.6 million in new investments at a weighted average cash cap rate of 7.7 %, exceeding its guidance range. Guidance for 2026 has been raised: AFFO per share is now forecast at $2.00‑$2.05 (up from $1.99‑$2.04) and investment volume guidance to $1.1 billion‑$1.5 billion (up from $1.0 b...

Full article

Essential Properties Realty Trust (EPRT) reported first‑quarter 2026 results that exceeded expectations across key metrics. Net income per share rose 13 % to $0.28, while Adjusted Funds From Operations (AFFO) per share increased 11 % to $0.50, matching the $0.5 per share FFO that beat the Zacks Consensus Estimate of $0.49 per share by 2.04 %. Reven...

Full article

The cost reduction was partly offset by an algae bloom in Southern Norway, which negatively impacted costs by around EUR 10 million or EUR/kg 0.13 for Norwegian volumes. The company's operational EBIT per kg through the value chain varied across regions, with Norway achieving EUR 2.40 and Scotland EUR 1.50. In Consumer Products, operational EBIT wa...

Full article

Mowi ASA's first quarter 2026 harvest volumes reached a record high, increasing by 26% year-over-year to 136 thousand tonnes. This exceeded the company's guided total harvest volume of 128k GWT for Q1 2026. The operational EBIT for the Group was approximately EUR 221 million in Q1 2026, with blended farming costs decreasing to EUR/kg 5.46 from EUR/...

Full article

Financially, Roche’s core medicines—Hemlibra, Phesgo, and Gazyva—continue to support revenue streams, with the company’s shares up 3 % year‑to‑date against an industry decline of 5.5 %. The combined clinical advances and sales momentum are expected to underpin investor expectations for a strong future outlook, while the fenebrutinib safety data wil...

Full article

Strategically, the fenebrutinib data reinforce Roche’s plan to broaden its neuroscience portfolio as Ocrevus approaches patent expiry in the coming decade. A first‑in‑class BTK inhibitor that could occupy the high‑efficacy oral niche in both relapsing MS and primary progressive MS would be a key growth driver for the pharmaceutical segment. Ens­pry...

Full article